Adams Respiratory Therapeutics, Inc. (1319439) SEC Filing 8-K Material Event for the period ending Friday, May 25, 2007

Adams Respiratory Therapeutics, Inc.

CIK: 1319439

View differences made from one to another to evaluate Adams Respiratory Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Adams Respiratory Therapeutics, Inc..


Assess how Adams Respiratory Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Adams Respiratory Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1319439
Form Type: 8-K Corporate News
Accession Number: 0000950144-07-005295
Submitted to the SEC: Wed May 30 2007 3:42:55 PM EST
Accepted by the SEC: Wed May 30 2007
Period: Friday, May 25, 2007
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:

Bookmark the Permalink: